Article
The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter.
The Journal of pharmacology and experimental therapeutics - 1 Jul 2009
Yang Xi, Liang Shun-Hsin, Weyant Denise M, Lazarus Philip, Gallagher Carla J, Omiecinski Curtis J
Abstract excerpt
Microsomal epoxide hydrolase (EPHX1) biotransforms epoxide derivatives of pharmaceuticals, including metabolites of certain antiepileptic medications, such as phenytoin and carbamazepine, and many environmental epoxides, such as those derived from butadiene, benzene, and carcinogenic polyaromatic hydrocarbons. We previously identified a far upstream promoter region, designated E1-b, in the EPHX1 gene that directs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
